Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HAEK.F
- Price
- -
- Stock movement up
- +0.75 (4.98%)
- Company name
- Haemato AG
- Exchange
- (F ,
- Currency
- EUR )
- Market cap
- 82.62M
- Ent value
- 102.69M
- Price/Sales
- -
- Price/Book
- 0.55
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -13.18%
- 1 year return
- -10.73%
- 3 year return
- -18.33%
- 5 year return
- -20.45%
- 10 year return
- -10.90%
Last updated: 2024-12-17
DIVIDENDS
HAEK.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 37.73 |
| Price to FCF | 42.07 |
| Price to EBITDA | 14.45 |
| EV to EBITDA | 17.96 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.55 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 5.23M |
| EPS (TTM) | - |
| FCF per share (TTM) | 0.38 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | 0.00 |
| Net income (TTM) | 0.00 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 13.94M |
| Net receivables | 23.30M |
| Total current assets | 77.31M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 183.45M |
| Accounts payable | 20.23M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 31.37M |
| Total liabilities | 34.00M |
| Shareholder's equity | 149.45M |
| Net tangible assets | 58.17M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 2.19M |
| Capital expenditures (TTM) | 226.00K |
| Free cash flow (TTM) | 1.96M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | 1.31% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| HAEK.F | S&P500 | |
| Current price drop from All-time high | -83.07% | -4.52% |
| Highest price drop | -93.57% | -56.47% |
| Date of highest drop | 11 Jun 2010 | 9 Mar 2009 |
| Avg drop from high | -61.51% | -11.07% |
| Avg time to new high | 353 days | 12 days |
| Max time to new high | 4483 days | 1805 days |
COMPANY DETAILS
Marketcap
82.62M
Marketcap category
Small-cap
Description
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Employees
76
Website
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found